Pulmonx Corporation

LUNG · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$14-$15-$14-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$5$0$6$6
Change in WC-$0$5-$5$1
Other Non-Cash$1$6$0-$0
Operating Cash Flow-$8-$4-$13-$7
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$2-$4-$1
Inv. Sales/Matur.$9$7$21$16
Other Inv. Act.$0$0$0$0
Investing Cash Flow$9$5$16$14
Financing Activities
Debt Repay.-$0-$0$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$1$0
Financing Cash Flow$0-$0$1$0
Forex Effect$0-$1-$0$0
Net Chg. in Cash$1$1$4$8
Supplemental Information
Beg. Cash$76$75$71$64
End Cash$77$76$75$71
Free Cash Flow-$8-$4-$14-$7
Pulmonx Corporation (LUNG) Financial Statements & Key Stats | AlphaPilot